CoChat

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

Thiébaud, Daniel, Leyvraz, Serge, von Fliedner, Vladimir, Perey, Lucien, Cornu, Pierre, Thiébaud, Sylviane, Burckhardt, Peter · 1991 · European Journal of Cancer and Clinical Oncology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

28 patients with progressing painful bone metastases (18 breast cancer, 9 myeloma and 1 low grade lymphoma) received pamidronate 60 mg by 24 h continuous infusion for at least 2 courses (range 2-12). In patients urinary calcium and hydroxyproline excretion significantly decreased in relation to diminution of bone resorption. 9 of 18 breast cancer patients and 8 of 9 evaluable patients with myeloma had symptomatic improvement. Sclerotic areas of previously lytic lesions appeared in 8 breast cancer patients and in 1 myeloma patient. Transient fever developed in 1 patient and local phlebitis in 2. Among the 28 patients, 15 did not receive any anticancer treatment or have any change of the anticancer therapy during pamidronate administration. Of 7 with breast cancer, 4 had an improvement of symptoms and 4 sclerosis on radiographs. Impressive control of symptoms was the major feature of 8 myeloma patients, but only 1 had radiographic sclerosis.

Overview

Integrity signals

Registry

Crossref · 10.1016/0277-5379(91)90056-j

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 3

  1. Silverberg, 1987, Cancer Statist, 37, 2
  2. Fleisch, 1987, Biphosphonates—history and experimental basis, Bone, 8, 23
  3. Boonenkamp, 1986, Two modes of action of biphosphonates on osteolytic resorption of mineralised bone matrix, Bone Min, 1, 27

Cited by

See all 75

Metadata

Authors
Thiébaud, D., Leyvraz, S., von Fliedner, V., Perey, L., Cornu, P., Thiébaud, S., & Burckhardt, P.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Leyvraz, Serge
Venue
European Journal of Cancer and Clinical Oncology
Publisher
Elsevier BV
Published
1991-01
Volume
27
Issue
1
Pages
37-41
ISSN
0277-5379 (ISSN-L)
OpenAlex
W1990483333
Cited by
75
References
25
Citations by year
2020: 1
FWCI
3.20
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Journal of Cancer and Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Medicine › Surgery › Management of metastatic bone disease
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
pamidronate, bone metastasis, breast cancer, multiple myeloma, indolent lymphoma, bisphosphonates, continuous infusion, bone resorption, urinary hydroxyproline, urinary calcium, sclerotic bone lesions, analgesia, adverse effects
MeSH terms
Pamidronate, Adult, Aged, Aged, 80 and over, Bone Neoplasms, Bone Resorption, Breast Neoplasms, Diphosphonates, Drug Evaluation, Female, Humans, Middle Aged, Multiple Myeloma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of bone metastases from breast cancer and myeloma with pamidronate. https://app.cochat.ai/papers/10.1016/0277-5379(91)90056-j
The paper
Thiébaud, D., Leyvraz, S., von Fliedner, V., Perey, L., Cornu, P., Thiébaud, S., & Burckhardt, P. (1991). Treatment of bone metastases from breast cancer and myeloma with pamidronate. European Journal of Cancer and Clinical Oncology. https://doi.org/10.1016/0277-5379(91)90056-j

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.